Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 256

1.

A contemporary review of male breast cancer: current evidence and unanswered questions.

Leon-Ferre RA, Giridhar KV, Hieken TJ, Mutter RW, Couch FJ, Jimenez RE, Hawse JR, Boughey JC, Ruddy KJ.

Cancer Metastasis Rev. 2018 Sep 19. doi: 10.1007/s10555-018-9761-x. [Epub ahead of print] Review.

PMID:
30232577
2.

Association of Low Nodal Positivity Rate Among Patients With ERBB2-Positive or Triple-Negative Breast Cancer and Breast Pathologic Complete Response to Neoadjuvant Chemotherapy.

Barron AU, Hoskin TL, Day CN, Hwang ES, Kuerer HM, Boughey JC.

JAMA Surg. 2018 Sep 5. doi: 10.1001/jamasurg.2018.2696. [Epub ahead of print]

PMID:
30193375
3.

Disease-Free and Overall Survival Among Patients With Operable HER2-Positive Breast Cancer Treated With Sequential vs Concurrent Chemotherapy: The ACOSOG Z1041 (Alliance) Randomized Clinical Trial.

Buzdar AU, Suman VJ, Meric-Bernstam F, Leitch AM, Ellis MJ, Boughey JC, Unzeitig GW, Royce ME, Hunt KK.

JAMA Oncol. 2018 Sep 6. doi: 10.1001/jamaoncol.2018.3691. [Epub ahead of print]

PMID:
30193295
4.

Tyrosine Phosphorylation of Mitochondrial Creatine Kinase 1 Enhances a Druggable Tumor Energy Shuttle Pathway.

Kurmi K, Hitosugi S, Yu J, Boakye-Agyeman F, Wiese EK, Larson TR, Dai Q, Machida YJ, Lou Z, Wang L, Boughey JC, Kaufmann SH, Goetz MP, Karnitz LM, Hitosugi T.

Cell Metab. 2018 Aug 23. pii: S1550-4131(18)30509-6. doi: 10.1016/j.cmet.2018.08.008. [Epub ahead of print]

PMID:
30174304
5.

ATR Inhibition Is a Promising Radiosensitizing Strategy for Triple-Negative Breast Cancer.

Tu X, Kahila MM, Zhou Q, Yu J, Kalari KR, Wang L, Harmsen WS, Yuan J, Boughey JC, Goetz MP, Sarkaria JN, Lou Z, Mutter RW.

Mol Cancer Ther. 2018 Aug 30. doi: 10.1158/1535-7163.MCT-18-0470. [Epub ahead of print]

PMID:
30166399
6.

Surgical Standards for Management of the Axilla in Breast Cancer Clinical Trials with Pathological Complete Response Endpoint.

Boughey JC, Alvarado MD, Lancaster RB, Fraser Symmans W, Mukhtar R, Wong JM, Ewing CA, Potter DA, Tuttle TM, Hieken TJ, Carter JM, Jakub JW, Kaplan HG, Buchanan CL, Jaskowiak NT, Sattar HA, Mueller J, Nanda R, Isaacs CJ, Pohlmann PR, Lynce F, Tousimis EA, Zeck JC, Lee MC, Lang JE, Mhawech-Fauceglia P, Rao R, Taback B, Chen M, Kalinsky KM, Hibshoosh H, Killelea B, Sanft T, Hirst GL, Asare S, Matthews JB, Perlmutter J, Esserman LJ; and I-SPY 2 Investigators.

NPJ Breast Cancer. 2018 Aug 17;4:26. doi: 10.1038/s41523-018-0074-6. eCollection 2018. Review.

7.

The Clinical Significance of Breast-only and Node-only Pathologic Complete Response (pCR) After Neoadjuvant Chemotherapy (NACT): A Review of 20,000 Breast Cancer Patients in the National Cancer Data Base (NCDB).

Fayanju OM, Ren Y, Thomas SM, Greenup RA, Plichta JK, Rosenberger LH, Tamirisa N, Force J, Boughey JC, Hyslop T, Hwang ES.

Ann Surg. 2018 Oct;268(4):591-601. doi: 10.1097/SLA.0000000000002953.

PMID:
30048319
8.

HGT-ID: an efficient and sensitive workflow to detect human-viral insertion sites using next-generation sequencing data.

Baheti S, Tang X, O'Brien DR, Chia N, Roberts LR, Nelson H, Boughey JC, Wang L, Goetz MP, Kocher JA, Kalari KR.

BMC Bioinformatics. 2018 Jul 17;19(1):271. doi: 10.1186/s12859-018-2260-9.

9.

The Feasibility of Breast-Conserving Surgery for Multiple Ipsilateral Breast Cancer: An Initial Report from ACOSOG Z11102 (Alliance) Trial.

Rosenkranz KM, Ballman K, McCall L, Kubicky C, Cuttino L, Le-Petross H, Hunt KK, Giuliano A, Van Zee KJ, Haffty B, Boughey JC.

Ann Surg Oncol. 2018 Oct;25(10):2858-2866. doi: 10.1245/s10434-018-6583-6. Epub 2018 Jul 9.

PMID:
29987605
10.

Lymphedema symptoms and limb measurement changes in breast cancer survivors treated with neoadjuvant chemotherapy and axillary dissection: results of American College of Surgeons Oncology Group (ACOSOG) Z1071 (Alliance) substudy.

Armer JM, Ballman KV, McCall L, Armer NC, Sun Y, Udmuangpia T, Hunt KK, Mittendorf EA, Byrd DR, Julian TB, Boughey JC.

Support Care Cancer. 2018 Jul 6. doi: 10.1007/s00520-018-4334-7. [Epub ahead of print]

PMID:
29980907
11.

Decreasing Use of Axillary Dissection in Node-Positive Breast Cancer Patients Treated with Neoadjuvant Chemotherapy.

Nguyen TT, Hoskin TL, Day CN, Degnim AC, Jakub JW, Hieken TJ, Boughey JC.

Ann Surg Oncol. 2018 Sep;25(9):2596-2602. doi: 10.1245/s10434-018-6637-9. Epub 2018 Jul 5.

PMID:
29978369
12.

Effect of Primary Breast Tumor Location on Axillary Nodal Positivity.

Desai AA, Hoskin TL, Day CN, Habermann EB, Boughey JC.

Ann Surg Oncol. 2018 Oct;25(10):3011-3018. doi: 10.1245/s10434-018-6590-7. Epub 2018 Jul 2.

PMID:
29968027
13.

'Nudging' Surgeons and Patients to De-Escalation of Surgery for Breast Cancer.

Yao K, Boughey JC.

Ann Surg Oncol. 2018 Oct;25(10):2777-2780. doi: 10.1245/s10434-018-6588-1. Epub 2018 Jul 2. No abstract available.

PMID:
29968025
14.

Predicting Non-sentinel Lymph Node Metastases in Patients with a Positive Sentinel Lymph Node After Neoadjuvant Chemotherapy.

Barron AU, Hoskin TL, Boughey JC.

Ann Surg Oncol. 2018 Oct;25(10):2867-2874. doi: 10.1245/s10434-018-6578-3. Epub 2018 Jun 28.

PMID:
29956095
15.

Treatment Outcomes for Pleomorphic Lobular Carcinoma In Situ of the Breast.

Desai AA, Jimenez RE, Hoskin TL, Day CN, Boughey JC, Hieken TJ.

Ann Surg Oncol. 2018 Oct;25(10):3064-3068. doi: 10.1245/s10434-018-6591-6. Epub 2018 Jun 26.

PMID:
29947004
16.

Prepectoral Implant-Based Breast Reconstruction with Postmastectomy Radiation Therapy.

Elswick SM, Harless CA, Bishop SN, Schleck CD, Mandrekar J, Reusche RD, Mutter RW, Boughey JC, Jacobson SR, Lemaine V.

Plast Reconstr Surg. 2018 Jul;142(1):1-12. doi: 10.1097/PRS.0000000000004453.

PMID:
29878988
17.

Neoadjuvant Chemotherapy Use in Breast Cancer is Greatest in Excellent Responders: Triple-Negative and HER2+ Subtypes.

Murphy BL, Day CN, Hoskin TL, Habermann EB, Boughey JC.

Ann Surg Oncol. 2018 Aug;25(8):2241-2248. doi: 10.1245/s10434-018-6531-5. Epub 2018 May 21.

PMID:
29786125
18.

Ability of Intraoperative Pathologic Analysis of Ductal Carcinoma In Situ to Guide Selective Use of Sentinel Lymph Node Surgery.

Murphy BL, Gonzalez AB, Keeney MG, Chen B, Conners AL, Henrichsen TL, Degnim AC, Harmsen WS, Boughey JC, Hieken TJ, Habermann EB, Jakub JW.

Am Surg. 2018 Apr 1;84(4):537-542.

PMID:
29712602
19.

DNA methyltransferase expression in triple-negative breast cancer predicts sensitivity to decitabine.

Yu J, Qin B, Moyer AM, Nowsheen S, Liu T, Qin S, Zhuang Y, Liu D, Lu SW, Kalari KR, Visscher DW, Copland JA, McLaughlin SA, Moreno-Aspitia A, Northfelt DW, Gray RJ, Lou Z, Suman VJ, Weinshilboum R, Boughey JC, Goetz MP, Wang L.

J Clin Invest. 2018 Jun 1;128(6):2376-2388. doi: 10.1172/JCI97924. Epub 2018 Apr 30.

20.

Discovery of a Glucocorticoid Receptor (GR) Activity Signature Using Selective GR Antagonism in ER-Negative Breast Cancer.

West DC, Kocherginsky M, Tonsing-Carter EY, Dolcen DN, Hosfield DJ, Lastra RR, Sinnwell JP, Thompson KJ, Bowie KR, Harkless RV, Skor MN, Pierce CF, Styke SC, Kim CR, de Wet L, Greene GL, Boughey JC, Goetz MP, Kalari KR, Wang L, Fleming GF, Györffy B, Conzen SD.

Clin Cancer Res. 2018 Jul 15;24(14):3433-3446. doi: 10.1158/1078-0432.CCR-17-2793. Epub 2018 Apr 10.

PMID:
29636357
21.

Factors Associated With Positive Margins in Women Undergoing Breast Conservation Surgery.

Murphy BL, Boughey JC, Keeney MG, Glasgow AE, Racz JM, Keeney GL, Habermann EB.

Mayo Clin Proc. 2018 Apr;93(4):429-435. doi: 10.1016/j.mayocp.2017.11.023. Epub 2018 Feb 10.

PMID:
29439832
22.

Axillary Ultrasound Identifies Residual Nodal Disease After Chemotherapy: Results From the American College of Surgeons Oncology Group Z1071 Trial (Alliance).

Le-Petross HT, McCall LM, Hunt KK, Mittendorf EA, Ahrendt GM, Wilke LG, Ballman KV, Boughey JC.

AJR Am J Roentgenol. 2018 Mar;210(3):669-676. doi: 10.2214/AJR.17.18295. Epub 2018 Jan 30.

23.

Establishing and characterizing patient-derived xenografts using pre-chemotherapy percutaneous biopsy and post-chemotherapy surgical samples from a prospective neoadjuvant breast cancer study.

Yu J, Qin B, Moyer AM, Sinnwell JP, Thompson KJ, Copland JA 3rd, Marlow LA, Miller JL, Yin P, Gao B, Minter-Dykhouse K, Tang X, McLaughlin SA, Moreno-Aspitia A, Schweitzer A, Lu Y, Hubbard J, Northfelt DW, Gray RJ, Hunt K, Conners AL, Suman VJ, Kalari KR, Ingle JN, Lou Z, Visscher DW, Weinshilboum R, Boughey JC, Goetz MP, Wang L.

Breast Cancer Res. 2017 Dec 6;19(1):130. doi: 10.1186/s13058-017-0920-8.

24.

A comprehensive analysis of breast cancer microbiota and host gene expression.

Thompson KJ, Ingle JN, Tang X, Chia N, Jeraldo PR, Walther-Antonio MR, Kandimalla KK, Johnson S, Yao JZ, Harrington SC, Suman VJ, Wang L, Weinshilboum RL, Boughey JC, Kocher JP, Nelson H, Goetz MP, Kalari KR.

PLoS One. 2017 Nov 30;12(11):e0188873. doi: 10.1371/journal.pone.0188873. eCollection 2017.

25.

Impact of Neoadjuvant Chemotherapy on Nodal Disease and Nodal Surgery by Tumor Subtype.

Al-Hilli Z, Hoskin TL, Day CN, Habermann EB, Boughey JC.

Ann Surg Oncol. 2018 Feb;25(2):482-493. doi: 10.1245/s10434-017-6263-y. Epub 2017 Nov 27.

PMID:
29181679
26.

Influence of Biologic Subtype of Inflammatory Breast Cancer on Response to Neoadjuvant Therapy and Cancer Outcomes.

Hieken TJ, Murphy BL, Boughey JC, Degnim AC, Glazebrook KN, Hoskin TL.

Clin Breast Cancer. 2018 Aug;18(4):e501-e506. doi: 10.1016/j.clbc.2017.10.003. Epub 2017 Oct 7.

PMID:
29089281
27.
28.

Use of 21-gene recurrence score assay to individualize adjuvant chemotherapy recommendations in ER+/HER2- node positive breast cancer-A National Cancer Database study.

Peethambaram PP, Hoskin TL, Day CN, Goetz MP, Habermann EB, Boughey JC.

NPJ Breast Cancer. 2017 Oct 19;3:41. doi: 10.1038/s41523-017-0044-4. eCollection 2017.

29.

Two studies pave the way for preoperative therapy in pancreatic cancer patients.

Katz MH, Ahmad SA, Boughey JC.

Bull Am Coll Surg. 2016 Aug;101(8):57-60.

PMID:
28941435
30.

Why is surgeon qualification important for clinical trials, and how can it be achieved?

Kurtzman SH, Boughey JC, You YN.

Bull Am Coll Surg. 2016 Sep;101(9):51-2. No abstract available.

PMID:
28941372
31.

Improving rectal cancer outcomes through advocacy, education, and research: The OSTRiCh Consortium and the new NAPRC.

Monson JRT, Dietz DW, Boughey JC, You YN.

Bull Am Coll Surg. 2016 Nov;101(11):45-6. No abstract available.

PMID:
28937195
32.

Surgery versus monitoring and endocrine therapy for low-risk DCIS: The COMET Trial.

Youngwirth LM, Boughey JC, Hwang ES.

Bull Am Coll Surg. 2017 Jan;102(1):62-3. No abstract available.

PMID:
28925613
33.

A new approach for advanced gastric cancer: Using PET scans as a biomarker of preoperative chemotherapy efficacy.

Shah M, Strong VE, Boughey JC.

Bull Am Coll Surg. 2017 Feb;102(2):46-8. No abstract available.

PMID:
28925240
34.

In search of the philosopher’s stone: The ALCHEMIST study for lung cancer.

Veeramachaneni N, Wigle D, Boughey JC.

Bull Am Coll Surg. 2017 Mar;102(3):37-8. No abstract available.

PMID:
28920661
35.

Junior investigators: Get engaged in the Alliance for Clinical Trials in Oncology.

Uy GL, Katz MHG, Boughey JC.

Bull Am Coll Surg. 2017 Apr;102(4):62-3.

36.

Tumor and serum DNA methylation in women receiving preoperative chemotherapy with or without vorinostat in TBCRC008.

Connolly RM, Fackler MJ, Zhang Z, Zhou XC, Goetz MP, Boughey JC, Walsh B, Carpenter JT, Storniolo AM, Watkins SP, Gabrielson EW, Stearns V, Sukumar S.

Breast Cancer Res Treat. 2018 Jan;167(1):107-116. doi: 10.1007/s10549-017-4503-2. Epub 2017 Sep 16.

PMID:
28918548
37.

Impact of histopathology, tumor-infiltrating lymphocytes, and adjuvant chemotherapy on prognosis of triple-negative breast cancer.

Leon-Ferre RA, Polley MY, Liu H, Gilbert JA, Cafourek V, Hillman DW, Elkhanany A, Akinhanmi M, Lilyquist J, Thomas A, Negron V, Boughey JC, Liu MC, Ingle JN, Kalari KR, Couch FJ, Visscher DW, Goetz MP.

Breast Cancer Res Treat. 2018 Jan;167(1):89-99. doi: 10.1007/s10549-017-4499-7. Epub 2017 Sep 14.

PMID:
28913760
38.

Interventions to promote better conversations about initial treatment for prostate cancer.

Kim SP, Tilburt JC, Boughey JC.

Bull Am Coll Surg. 2017 May;102(5):48-9. No abstract available.

PMID:
28892327
39.

ACS CRP Dissemination and Implementation Committee issues call for participants in pilot project.

Dickson-Witmer D, Blair S, Boughey JC.

Bull Am Coll Surg. 2017 Jun;102(6):48-50.

PMID:
28885810
40.

Gastrectomy for cancer: What are the benefits of a minimally invasive approach?

Strand MS, Strong VE, Fields RC, Boughey JC.

Bull Am Coll Surg. 2017 Jul;102(7):68-70. No abstract available.

PMID:
28885793
41.

Incorporation of Treatment Response, Tumor Grade and Receptor Status Improves Staging Quality in Breast Cancer Patients Treated with Neoadjuvant Chemotherapy.

Bergquist JR, Murphy BL, Storlie CB, Habermann EB, Boughey JC.

Ann Surg Oncol. 2017 Nov;24(12):3510-3517. doi: 10.1245/s10434-017-6010-4. Epub 2017 Aug 21.

PMID:
28828583
42.

Localizing the Clipped Node in Patients with Node-Positive Breast Cancer Treated with Neoadjuvant Chemotherapy: Early Learning Experience and Challenges.

Nguyen TT, Hieken TJ, Glazebrook KN, Boughey JC.

Ann Surg Oncol. 2017 Oct;24(10):3011-3016. doi: 10.1245/s10434-017-6023-z. Epub 2017 Aug 1.

PMID:
28766234
43.

Contralateral Prophylactic Mastectomy with Immediate Breast Reconstruction Increases Healthcare Utilization and Cost.

Boughey JC, Schilz SR, Van Houten HK, Zhu L, Habermann EB, Lemaine V.

Ann Surg Oncol. 2017 Oct;24(10):2957-2964. doi: 10.1245/s10434-017-5983-3. Epub 2017 Aug 1.

PMID:
28766231
44.

Breast Cancer-Related Lymphedema Risk is Related to Multidisciplinary Treatment and Not Surgery Alone: Results from a Large Cohort Study.

Nguyen TT, Hoskin TL, Habermann EB, Cheville AL, Boughey JC.

Ann Surg Oncol. 2017 Oct;24(10):2972-2980. doi: 10.1245/s10434-017-5960-x. Epub 2017 Aug 1.

45.

Changing Dogma and Decreased Collateral Damage in Breast Cancer Care.

Mendez J, Boughey JC.

Ann Surg Oncol. 2017 Oct;24(10):2801-2803. doi: 10.1245/s10434-017-5937-9. Epub 2017 Aug 1. No abstract available.

PMID:
28766227
46.

Clinical Decision-Making in Patients with Variant of Uncertain Significance in BRCA1 or BRCA2 Genes.

Welsh JL, Hoskin TL, Day CN, Thomas AS, Cogswell JA, Couch FJ, Boughey JC.

Ann Surg Oncol. 2017 Oct;24(10):3067-3072. doi: 10.1245/s10434-017-5959-3. Epub 2017 Aug 1.

47.

Factors Influencing Use of Hormone Therapy for Ductal Carcinoma In Situ: A National Cancer Database Study.

Nguyen TT, Hoskin TL, Day CN, Habermann EB, Goetz MP, Boughey JC.

Ann Surg Oncol. 2017 Oct;24(10):2989-2998. doi: 10.1245/s10434-017-5930-3. Epub 2017 Aug 1.

PMID:
28766214
48.

Selective Use of Sentinel Lymph Node Surgery in Patients Undergoing Prophylactic Mastectomy Using Intraoperative Pathology.

Murphy BL, Glasgow AE, Keeney GL, Habermann EB, Boughey JC.

Ann Surg Oncol. 2017 Oct;24(10):3032-3037. doi: 10.1245/s10434-017-5925-0. Epub 2017 Aug 1.

PMID:
28766201
49.

Predicting Nodal Positivity in Women 70 Years of Age and Older with Hormone Receptor-Positive Breast Cancer to Aid Incorporation of a Society of Surgical Oncology Choosing Wisely Guideline into Clinical Practice.

Welsh JL, Hoskin TL, Day CN, Habermann EB, Goetz MP, Boughey JC.

Ann Surg Oncol. 2017 Oct;24(10):2881-2888. doi: 10.1245/s10434-017-5932-1. Epub 2017 Aug 1.

PMID:
28766197
50.

A Validated Nomogram to Predict Upstaging of Ductal Carcinoma in Situ to Invasive Disease.

Jakub JW, Murphy BL, Gonzalez AB, Conners AL, Henrichsen TL, Maimone S 4th, Keeney MG, McLaughlin SA, Pockaj BA, Chen B, Musonza T, Harmsen WS, Boughey JC, Hieken TJ, Habermann EB, Shah HN, Degnim AC.

Ann Surg Oncol. 2017 Oct;24(10):2915-2924. doi: 10.1245/s10434-017-5927-y. Epub 2017 Aug 1.

PMID:
28766196

Supplemental Content

Loading ...
Support Center